Ben George

7.1k total citations · 1 hit paper
151 papers, 2.8k citations indexed

About

Ben George is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ben George has authored 151 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 68 papers in Pulmonary and Respiratory Medicine and 39 papers in Cancer Research. Recurrent topics in Ben George's work include Pancreatic and Hepatic Oncology Research (71 papers), Cancer Genomics and Diagnostics (38 papers) and Colorectal Cancer Treatments and Studies (21 papers). Ben George is often cited by papers focused on Pancreatic and Hepatic Oncology Research (71 papers), Cancer Genomics and Diagnostics (38 papers) and Colorectal Cancer Treatments and Studies (21 papers). Ben George collaborates with scholars based in United States, United Kingdom and Japan. Ben George's co-authors include Susan Tsai, Kathleen K. Christians, Bradley A. Erickson, Douglas B. Evans, Paul S. Ritch, Fabian M. Johnston, Mohammed Aldakkak, James P. Thomas, William A. Hall and Parag Tolat and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ben George

145 papers receiving 2.8k citations

Hit Papers

Pertuzumab and trastuzumab for HER2-positive, metastatic ... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
    2021 251 citations Milind Javle, Mitesh J. Borad et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben George United States 28 1.9k 1.0k 923 630 429 151 2.8k
Cheuk‐Wai Choi Hong Kong 26 1.2k 0.6× 908 0.9× 1.2k 1.3× 323 0.5× 197 0.5× 103 2.8k
Joanne F. Chou United States 32 2.1k 1.1× 1.0k 1.0× 964 1.0× 250 0.4× 227 0.5× 92 3.3k
A. William Blackstock United States 31 1.7k 0.9× 1.7k 1.7× 711 0.8× 350 0.6× 529 1.2× 129 3.1k
Chi Lin United States 26 851 0.4× 728 0.7× 489 0.5× 284 0.5× 309 0.7× 144 2.1k
Cordula Petersen Germany 32 1.0k 0.5× 981 0.9× 624 0.7× 443 0.7× 385 0.9× 116 2.7k
Erqi L. Pollom United States 27 924 0.5× 1.0k 1.0× 612 0.7× 320 0.5× 537 1.3× 195 2.8k
Baruch Brenner Israel 34 2.3k 1.2× 816 0.8× 1.0k 1.1× 274 0.4× 571 1.3× 158 3.8k
Amol Narang United States 21 1.2k 0.6× 705 0.7× 496 0.5× 365 0.6× 289 0.7× 140 2.1k
D. Hölzel Germany 30 2.0k 1.0× 791 0.8× 905 1.0× 671 1.1× 258 0.6× 126 3.2k
Charles Cha United States 24 973 0.5× 692 0.7× 600 0.7× 391 0.6× 509 1.2× 79 2.5k

Countries citing papers authored by Ben George

Since Specialization
Citations

This map shows the geographic impact of Ben George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben George more than expected).

Fields of papers citing papers by Ben George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben George. The network helps show where Ben George may publish in the future.

Co-authorship network of co-authors of Ben George

This figure shows the co-authorship network connecting the top 25 collaborators of Ben George. A scholar is included among the top collaborators of Ben George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben George. Ben George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Owczarczyk, Kasia, Ben George, Veni Ezhil, et al.. (2025). 1780 Clinical and dosimetric outcomes of Stereotactic MR-guided adaptive radiotherapy (SMART) reirradiation for Liver Metastases. Radiotherapy and Oncology. 206. S1778–S1780.
2.
3.
4.
Aldakkak, Mohammed, Kathleen K. Christians, Callisia N. Clarke, et al.. (2023). Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. Journal of Surgical Oncology. 128(1). 41–50. 2 indexed citations
5.
Thapa, Bicky, Anikó Szabó, Gulrayz Ahmed, et al.. (2023). ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 41(4_suppl). 754–754. 1 indexed citations
6.
Shreenivas, Aditya, Filip Jankú, Mohamed A. Gouda, et al.. (2023). ALK fusions in the pan-cancer setting: another tumor-agnostic target?. npj Precision Oncology. 7(1). 101–101. 44 indexed citations
7.
Kamgar, Mandana, Ben George, Mohammed Aldakkak, et al.. (2023). CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer. Annals of Surgical Oncology. 30(5). 3013–3021. 6 indexed citations
8.
9.
Javle, Milind, Mitesh J. Borad, Nilofer S. Azad, et al.. (2021). Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study. The Lancet Oncology. 22(9). 1290–1300. 251 indexed citations breakdown →
10.
Aldakkak, Mohammed, Kathleen K. Christians, Callisia N. Clarke, et al.. (2021). Goal-directed neoadjuvant treatment of operable pancreatic cancer: achieving CA19-9 response to chemotherapy prior to surgery. HPB. 23. S478–S479. 1 indexed citations
11.
Gurney‐Champion, Oliver J., Faisal Mahmood, Robert Julian, et al.. (2020). Quantitative imaging for radiotherapy purposes. Radiotherapy and Oncology. 146. 66–75. 66 indexed citations
12.
Abid, Muhammad Bilal, Saurabh Chhabra, Blake W. Buchan, et al.. (2020). Bronchoalveolar lavage-based COVID-19 testing in patients with cancer. Hematology/Oncology and Stem Cell Therapy. 14(1). 65–70. 14 indexed citations
13.
Bluemke, Emma, Daniel P. Bulte, Ben George, et al.. (2020). Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma. Clinical and Translational Radiation Oncology. 22. 44–49. 5 indexed citations
14.
Speight, R., Maria A. Schmidt, Gary Liney, et al.. (2019). IPEM Topical Report: A 2018 IPEM survey of MRI use for external beam radiotherapy treatment planning in the UK. Physics in Medicine and Biology. 64(17). 175021–175021. 16 indexed citations
15.
Kim, Joohyun, et al.. (2019). Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study. Journal of Surgical Research. 242. 23–30. 25 indexed citations
16.
Barnes, Chad A., Ashley N. Krepline, Mohammed Aldakkak, et al.. (2017). Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?. Journal of Gastrointestinal Surgery. 21(11). 1793–1803. 23 indexed citations
17.
George, Ben, Karen Kelly, Amy Ko, et al.. (2016). Phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) in solid tumors: results from the pancreatic cancer (PC) and non-small cell lung cancer (NSCLC) cohorts. Annals of Oncology. 27. vi363–vi363. 2 indexed citations
18.
Krepline, Ashley N., Kathleen K. Christians, Ben George, et al.. (2016). Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated?. Journal of Surgical Oncology. 114(5). 581–586. 20 indexed citations
19.
Miura, John T., Fabian M. Johnston, Susan Tsai, et al.. (2015). Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 22(11). 3716–3723. 76 indexed citations
20.
Christians, Kathleen K., Ben George, Paul S. Ritch, et al.. (2015). Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. Surgery. 159(3). 893–900. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheuk‐Wai Choi Breakdown of academic impact, for papers by Joanne F. Chou Breakdown of academic impact, for papers by A. William Blackstock Breakdown of academic impact, for papers by Chi Lin Breakdown of academic impact, for papers by Cordula Petersen Breakdown of academic impact, for papers by Erqi L. Pollom Breakdown of academic impact, for papers by Baruch Brenner Breakdown of academic impact, for papers by Amol Narang Breakdown of academic impact, for papers by D. Hölzel Breakdown of academic impact, for papers by Charles Cha
Rankless by CCL
2026